BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Tilton CS, Johnson SW. Development of a risk prediction model for hospital-onset Clostridium difficile infection in patients receiving systemic antibiotics. American Journal of Infection Control 2019;47:280-4. [DOI: 10.1016/j.ajic.2018.08.021] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Hurley JC. Oral Vancomycin Prophylaxis for Clostridioides difficile Infection: Cause or Effect? Clin Infect Dis 2021;73:e2850-1. [PMID: 32948875 DOI: 10.1093/cid/ciaa1424] [Reference Citation Analysis]
2 Shirazi OU, Ab Rahman NS, Zin CS. A Narrative Review of Antimicrobial Stewardship Interventions within In-patient Settings and Resultant Patient Outcomes. J Pharm Bioallied Sci 2020;12:369-80. [PMID: 33679082 DOI: 10.4103/jpbs.JPBS_311_19] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
3 Marra AR, Alzunitan M, Abosi O, Edmond MB, Street WN, Cromwell JW, Salinas JL. Modest Clostridiodes difficile infection prediction using machine learning models in a tertiary care hospital. Diagn Microbiol Infect Dis 2020;98:115104. [PMID: 32650284 DOI: 10.1016/j.diagmicrobio.2020.115104] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Skyum F, Pedersen C, Andersen V, Chen M, Franke A, Petersen D, Ries W, Mogensen CB. Risk factors for contagious gastroenteritis in adult patients with diarrhoea in the emergency department - a prospective observational multicentre study. BMC Infect Dis 2019;19:133. [PMID: 30744568 DOI: 10.1186/s12879-019-3754-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Johnson SW, Brown SV, Priest DH. Effectiveness of Oral Vancomycin for Prevention of Healthcare Facility-Onset Clostridioides difficile Infection in Targeted Patients During Systemic Antibiotic Exposure. Clin Infect Dis 2020;71:1133-9. [PMID: 31560051 DOI: 10.1093/cid/ciz966] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 16.0] [Reference Citation Analysis]
6 Tilton CS, Sexton M, Johnson SW, Gu C, Chen Z, Robichaux C, Metzger NL. Evaluation of a risk assessment model to predict infection with healthcare facility-onset Clostridioides difficile. Am J Health Syst Pharm 2021:zxab201. [PMID: 33954428 DOI: 10.1093/ajhp/zxab201] [Reference Citation Analysis]